TRANSFUSION SCIENCE ARTICLES

In its 2024 annual report, the Serious Hazards of Transfusion (SHOT) scheme shows evidence of a particularly challenging year for staff working in transfusion laboratories.

The Serious Hazards of Transfusion (SHOT) scheme has recently published its Annual Report, collecting and analysing information on serious adverse events in blood transfusion within the UK. SHOT Laboratory Incident Specialist Victoria Tuckley presents a summary of its key points.

The appropriate selection of blood for transfusion in the ongoing treatment of patients with sickle cell disease is of vital importance. Here, Hannah Caldwell examines the role of sickle solubility testing and molecular genotyping in the care of SCD patients in Northern Ireland.

The 2022 Annual Report from the Serious Hazards of Transfusion (SHOT) scheme has been published recently, once again collecting and analysing anonymised information on serious adverse events and reactions in blood transfusion from all healthcare organisations. Here SHOT Laboratory Incident Specialist Victoria Tuckley summarises its key points and recommendations.

Nicola Swarbrick, Laboratory Incident Specialist at the Serious Hazards of Transfusion scheme, presents the key findings and recommendations from its 2021 report, which also marks 25 years since it was created to oversee and review haemovigilance reporting.

In this article, Serious Hazards of Transfusion laboratory incident specialist Nicola Swarbrick focuses on a specific area of transfusion science haemovigilance practice – incident investigation – that was the topic of a SHOT webinar held last year.